--- title: "GTX: Q2 2026 delivered strong sales and margin growth, with an improved 2026 outlook and active capital returns" type: "News" locale: "en" url: "https://longbridge.com/en/news/294196981.md" description: "Q2 2026 saw 7% net sales growth and a 23% increase in Adjusted EBIT, with margin expansion and strong cash flow. The outlook for 2026 was raised across all key metrics, supported by robust segment performance and continued capital returns to shareholders.Original document: Garrett Motion Inc. [GTX] Slides Release — Jul. 29 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source." datetime: "2026-07-29T11:06:39.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294196981.md) - [en](https://longbridge.com/en/news/294196981.md) - [zh-HK](https://longbridge.com/zh-HK/news/294196981.md) generator: "portal-rs" --- # GTX: Q2 2026 delivered strong sales and margin growth, with an improved 2026 outlook and active capital returns Q2 2026 saw 7% net sales growth and a 23% increase in Adjusted EBIT, with margin expansion and strong cash flow. The outlook for 2026 was raised across all key metrics, supported by robust segment performance and continued capital returns to shareholders. Original document: Garrett Motion Inc. \[GTX\] Slides Release — Jul. 29 2026 **Disclaimer** This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source. ### Related Stocks - [GTX.US](https://longbridge.com/en/quote/GTX.US.md) ## Related News & Research - [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md) - [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md) - [DE: 3Q 2026 saw sales and profit growth, but FY 2026 guidance signals industry headwinds](https://longbridge.com/en/news/296475895.md) - [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md) - [Algorhythm Holdings Reports Second Quarter 2026 Financial Results](https://longbridge.com/en/news/296124832.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**